BLOG

Osteoboost CEO Laura Yecies walking while wearing Osteoboost

Empowering Women to Take Control of Their Bone Health: Osteoboost Launches Nationwide

By Laura Yecies, CEO of Osteoboost Today represents an important milestone for women’s bone health.  My interest in bone health began in college, while working at a nursing home. I saw firsthand how hip fractures could change a person’s life. Years later, I watched my mother and grandmother navigate osteoporosis.…
Read more

Osteoboost in the News

Catch up on the latest news coverage of Bone Health Technologies and the breakthrough Osteoboost belt for osteopenia treatment.

Osteoboost Launches in the U.S. includes three pictures of women wearing the Osteoboost belt

Osteoboost Health Launches FDA-Cleared Prescription Wearable Device for Low Bone Density, Filling Critical Treatment Gap for 60M+ Americans

Redwood City, CA, May 7, 2025 – Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for low bone density. Osteoboost represents a novel, protective and preventative approach to bone health at a time when tens of millions are left without…
Read more

Medications and inject-able pens sit on a counter to illustrate the relationship between GLP-1-medications-and-low-bone-density

GLP-1 Medications and Low Bone Density: What You Need to Know to Protect Your Bones

By Laura Yecies If you’re taking a GLP-1 medication like Ozempic or Wegovy, chances are you’re on a journey to improve your health and longevity. These medications have been life-changing for people struggling with obesity and type 2 diabetes, offering effective weight loss and better metabolic control. But there’s one…
Read more

Approval Through FDA’s De Novo Pathway:  A Major Accomplishment!

By Michael Jaasma, PhD, Co-founder and Chief Scientific Officer at Osteoboost Health In January 2024, Osteoboost achieved a notable regulatory milestone by receiving De Novo classification from the U.S. Food and Drug Administration (FDA). This designation is significant not only because FDA approval is a rigorous process but also because…
Read more

Osteoboost Health, Inc. Awarded 6th U.S. Patent for Osteoboost, a Wearable Device for Bone Density Improvement

FOR IMMEDIATE RELEASE REDWOOD CITY, CALIF – March 3, 2025: Osteoboost Health Inc. today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 12,232,993 for Osteoboost, the first FDA-cleared wearable device designed to treat osteopenia and improve bone health through targeted vibration therapy, and…
Read more

Addressing Disparities in Osteoporosis Care and Outcomes for Black Americans

By Laura Yecies, CEO @Osteoboost Osteoporosis, a condition characterized by weakened bones and an increased risk of fractures, affects millions worldwide. While often perceived as predominantly impacting White populations, osteoporosis significantly affects Black individuals, who face unique challenges in diagnosis, treatment, and outcomes. In honor of Black History Month, it’s…
Read more

Group of people drinking a beer in a pub. Drinking adds risk to people with low bone density such as osteoporosis and osteopenia.

Alcohol and Bone Health: How Your Drinking Affects Bone Density and Strength

By Laura Yecies, CEO @ Osteoboost. It’s Friday at 5 p.m., and your coworkers are headed out for a few drinks to blow off steam. Or it’s Sunday afternoon and the carafe of mimosas is brought to the table. But you hesitate. Your doctor says you have osteopenia. What are…
Read more